[ad_1]
Photo of Papa Ruvicius (Reuters / Scanpix)
The European Union (EU) has agreed to purchase up to 300 million pfizer COVID-19 vaccines, which have reached Pfizer and BioNTech. vaccine dose.
Added: First COVID-19 vaccines in the EU in 2021
Once the vaccine has been shown to be safe and effective in combating COVID-19, Member States will be able to purchase € 200 million under the agreement. dose of vaccine. It is also possible to buy an additional 100 million. dose.
For the news when BioNTech and Pfizer announced their achievements in vaccine development on Monday, and today we can be proud of the $ 300 million agreement reached with them. purchase of vaccine doses. This is our fourth vaccine purchase agreement and we now have a very strong vaccine package available. Clinical trials for many vaccines are nearing completion. As soon as they are approved, they will be sent quickly to the recipients and this will help us to bring the end of the pandemic closer, according to the press release of the EC, Ursula von der Leyen, President of the EC.
Pfizer has announced that it will begin distributing the vaccine at the end of the year as soon as it is approved by the European Medicines Agency.
today we have entered into an agreement with the European Commission on the purchase of the vaccine. The agreement is the latest negotiated between Pfizer and BioNTech so far, and a major step towards an increasingly common goal of making the vaccine available to the world’s suffering population, the Financial Times quotes Albert Bourl, Pfizer director, as quoted.
V recalls that phase III clinical trials have shown that the COVID-19 vaccine developed by Pfizer and BioNTech is more than 90% effective. This requires that the first dose can be reached by the end of this year, subject to authorization from the relevant authorities.
According to the Financial Times, the efficacy of the vaccine was confirmed in phase III clinical trials, in which the vaccine was tested in 43,000 volunteers. After two doses administered 28 days apart, the small amount of infected virus allowed evaluators to estimate the effectiveness of the vaccine.
These studies are the final stage before obtaining a license to distribute the vaccine. In more than a decade of companies currently working on the vaccine, Pfizer and BioNTech were the first to complete phase III clinical trials.
In addition to the agreement with Pfizer and BioNTech, the EC also approved three agreements on a potential vaccine with one of Johnson & Johnson’s pharmaceutical companies, Janssen Pharmaceutical Pharmacy NV, and the EC has already signed agreements with AstraZeneca and Sanofi-GSK and has completed successful negotiations with CureVac and Moderna.
The first COVID-19 vaccines in the EU in 2021
The first vaccines against the COVID-19 coronavirus infection can be launched in the European Union no later than 2021. referred to the Head of the Community Health Agency on Wednesday.
But I can’t say more precisely, says AFP news agents Andrea Ammon, director of the European Center for Disease Prevention and Control (ECDC) in Stockholm.
An EU source told AFP on Tuesday that any vaccine could be approved for use in the Community from early 2021.
Mr. Ammon ini was cautious with the results obtained by Pfizer and BioNTech.
Inoma, she’s adorable, admits A. Ammon, but cautioned that so far the cassette was released only in a press release, not a peer-reviewed article.
Therefore, a final evaluation is needed. Any vaccine distributed in the European Union must be approved by the European Medicines Agency (EMA).
Mr. Ammon says that the spread of the COVID-19 pandemic in Europe is very, very worrying and that all the angels are showing that we are moving in the wrong direction right now.
According to her, the reduction in the number of daily infections may take longer than it took in Europe to eliminate the first wave of coronavirus in March and April.
The ECDC director has urged Europeans to adhere to the measures and measures in place to help control the spread of the virus. They must understand that it is crucial for them to contribute to the management of the epidemic according to the measure, said Mr. Ammon.
EU Health Commissioner Stela Kiriakides reiterated on Wednesday that the pandemic will end more than once with vaccines.
We need to understand that once we have a safe and effective vaccine, it will not be a silver bullet that forces COVID-19 to pass overnight, he told reporters.
According to the Commissioner, containment measures should continue until the required part of the population has been vaccinated.
Rayti komentar
[ad_2]
